Prescription Drug Data Collection (RxDC) Reporting

  • October 20, 2022

    Under the Consolidated Appropriations Act, 2021 (CAA), health issuers offering group or individual health coverage and self-funded group health plans must submit detailed data on prescription drug pricing and healthcare spending. This data submission is called the Prescription Drug Data Collection (RxDC) Report.

    The RxDC report is due annually, beginning December 27, 2022 (for reference years 2020 and 2021), and then by June 1 of each subsequent year. Required entities must submit the report through a web portal managed by The Centers for Medicare & Medicaid Services (CMS), which will collect the data on behalf of the Departments of Health and Human Services, the Department of Labor, and the Department of Treasury (Tri-Agencies).

    The reporting requirements include information intended to identify the significant drivers of increases in prescription drug and healthcare costs, increase understanding of how prescription drug rebates impact premiums and out-of-pocket costs, and improve prescription drug pricing transparency.

    What data is required?

    Plans, issuers, and carriers must submit one or more plan lists, eight data files, and a narrative response.

    1. Plan Lists
      2. P1 Individual and Student Market Plans
      P2 Group Health Plan list
      P3 FEHB (federal employee health benefit) plan list

    2. Data Files
      3. D1 Premium and Life Years
      D2 Spending by Category
      D3 Top 50 Most Frequent Brand Drugs
      D4 Top 50 Most Costly Drugs
      D5 Top 50 Drugs by Spending Increase
      D6 Rx Totals
      D7 Rx Rebates by Therapeutic Class
      D8 Rx Rebates for the Top 25 Drugs

    3. Narrative Response(s)

    How will this data be used?

    The Department of Health and Human Services (HHS) must post a report on prescription drug reimbursements for plans and coverage, prescription drug pricing trends, and the role of prescription drug costs in contributing to premium increases or decreases under these plans or coverage. However, HHS will aggregate the information so that no drug or plan-specific information is made public.

    Premera's approach

    Fully insured, OptiFlex, and Self-funded business
    Although Premera is not responsible for compliance, we intend to include in our aggregate reporting any required data that we house on behalf of our group business as a courtesy. The reporting includes P2, D1-D8, and any narrative responses.

    Pharmacy carve-out groups
    Premera intends to submit the following reporting for groups that carveout pharmacy:

    • P2-Group Health Plan List
    • D1-Premium and Life-Years
    • D2-Spending by Category
    • Any required narrative responses

    Clients with carve-out arrangements should coordinate with other carriers to ensure they report all required information.

    Terminated groups
    Premera will submit reporting for a group's active period during a given reference year. For example, the initial reporting due date of December 27, 2022, includes data from reference years 2020 and 2021. Terminated groups should work with their other vendors to submit reporting for any periods during which Premera did not cover them.

    Average premium data
    The departments will not enforce the requirement to report the average monthly premium paid by employers versus members for the 2020 and 2021 reference years if those data elements are unavailable. As a result, Premera will not include that information for the 2020 and 2021 reporting due December 27, 2022.

    Please contact your Premera account representative if you have questions about Premera's approach to this requirement.

  •    Email this article